Until about 10 years ago, conventional prostate cancer treatments were based on the assumption that prostate cancer is a multifocal disease. All conventional treatment modalities (surgery, radiotherapy, and thermal ablation) were “radical” because they were directed at the removal or destruction of the whole gland. Such treatments, however, put urinary and sexual function at risk, keep reading
If you have prostate cancer, how satisfied are you with the clinical services you received during the diagnosis and treatment process? According to a study by Gupta et al. published in the journal Health and Quality of Life Outcomes, the more satisified you are, the greater your chances of survival.[i] Patients’ self-perceptions, attitudes and outlook keep reading
The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into keep reading
An update on COVID-19: Your health and safety are our top priority.